Maryland Capital Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $310K | Hold |
5,829
| – | – | 0.03% | 181 |
|
|
2022
Q2 | $340K | Buy |
5,829
+1,339
| +30% | +$78.1K | 0.03% | 178 |
|
|
2022
Q1 | $343K | Buy |
4,490
+107
| +2% | +$8.17K | 0.02% | 194 |
|
|
2021
Q4 | $264K | Buy |
4,383
+479
| +12% | +$28.9K | 0.01% | 232 |
|
|
2021
Q3 | $219K | Buy |
3,904
+391
| +11% | +$21.9K | 0.01% | 237 |
|
|
2021
Q2 | $213K | Sell |
3,513
-557
| -14% | -$33.8K | 0.01% | 248 |
|
|
2021
Q1 | $285K | Buy |
+4,070
| New | +$285K | 0.02% | 205 |
|